Biotech (XBI) Breakout

Popular Articles

By Mike Paulenoff | Published 03/2/2010 | Stocks | Unrated

Biotech (XBI) Breakout

Yesterday’s powerful upside breakout in the SPDR S&P Biotech ETF (XBI) continues today as the biotech sector remains “bid” in expectation of more takeover action and pipeline news. Yesterday was OSI Pharmaceuticals (OSIP), today was Dendreon (DNDN), with many other names in the group acting well, such as CELG, CEPH, BIIB, HGSI. As for the technical work, the XBI has an optimal target in the vicinity of 63.00 in the upcoming days.

Mike Paulenoff is a 26-year veteran of the financial markets and author of MPTrader.com.

It should not be assumed that the methods, techniques, or indicators presented on these websites will be profitable or that they will not result in losses. Past results are not necessarily indicative of future results. Examples presented on these websites are for educational purposes only. These set-ups are not solicitations of any order to buy or sell. The authors, Tiger Shark Publishing LLC, and all affiliates assume no responsibility for your trading results. There is a high degree of risk in trading.